Browsing by Author Gibbs, Emma

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)Citation
2017Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: Exploratory analyses of the AURELIA trialDavies, Lucy; Gebski, Val; Gibbs, Emma; Lee, C.; Veillard, Anne-Sophie; Bamias, A; Bloemendal, H; Dimopoulos, M; Floquet, A.; Kosse, J; Lykka, M; Mirza, Mansoor Raza; Pujade-Lauraine, Eric; santaballa, A; Tabaro, G; Vergote, I; Zagouri, F; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: Exploratory analyses of the AURELIA trial, Annals of Oncology, vol.28, 8, 2017,pp 1842-1848
2017Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)Gebski, Val; Gibbs, Emma; Lindemann, Kristina; Auranen, Annika; Avall-Lundqvist, Elisabeth; dePont Christensen, Rene; Dorum, Anne; Grenman, Seija; Hjerpe, Elisabet; Hoegberg, Thomas; Kalling, Marten; Kristensen, G; Rosenberg, Per; Skeie-Jensen, Tone; Woie, Kathrine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreChemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist), British Journal of Cancer, vol.116, 4, 2017,pp 455-463
2015Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinibGibbs, Emma; Lee, Chee Khoon; Lord, Sarah (Sally); Casali, Paolo G.; Cioffi, Angela; et al, Various; Goldstein, David; Joensuu, Heikki; Maki, Robert; Verweij, Jaap; Zalcberg, John; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreDevelopment and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib, European Journal of Cancer, vol.51, 7, 2015,pp 852-860
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2017Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudyAsher, Rebecca; Davies, Lucy; Gebski, Val; Gibbs, Emma; King, Madeleine; Lee, Chee Khoon; Roncolato, Felicia; Stockler, Martin; Friedlander, Michael; Hilpert, Felix; Pujade-Lauraine, Eric; Wenzel, Lari; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreQuality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy, Annals of Oncology, vol.28, 8, 2017,pp 1849-1855
2017Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centreClarke, Stephen; Diakos, Connie; Gibbs, Emma; Gill, Anthony; Hruby, George; Itchins, Malinda; Kneebone, Andrew; Mittal, Anubhav; Nahm, Christopher; Pavlakis, Nick; Rabindran, Joel; Samra, Jaswinder; Arena, Jennifer; Bergamin, S.; Chua, Terence; Kim, Stefano; Maher, Richard; Wong, M.; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; Northern Clinical School: Pathology; Central Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Surgery; Northern Clinical School: Surgery; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: SurgeryRetrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre, European Journal of Surgical Oncology, vol.43, 9, 2017,pp 1711-1717
2017Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trialGebski, Val; Gibbs, Emma; Lee, Chee Khoon; Coeffic, D; et al, Various; Garcia, Yolanda; Hilbert, Felix; Huizing, M; Kaern, Janne; Roemer-Becuwe, C; Sorio, R; Witteveen, P; Zagouri, F; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreSafety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial, Gynecologic Oncology, vol.144, 1, 2017,pp 65-71
2017Smartphone use in dermatology for clinical photography and consultation: Current practice and the lawAbbott, Lisa; Gibbs, Emma; Magnusson, Roger; Smith, Saxon; Law; NH&MRC Clinical Trials Centre; Law; Northern Clinical School: General PracticeSmartphone use in dermatology for clinical photography and consultation: Current practice and the law, Australasian Journal of Dermatology, vol.58, 4, 2017,pp e216-e222
2016Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicityBarnes, Elizabeth; Gibbs, Emma; King, Madeleine; Livingstone (nee Ratcliffe), Ann; Lovell, Melanie Ruth; Sawkins, Kate; Vardy, Janette; Agar, Meera; Chye, Richard; Clark, Katherine; Hovey, E.; Koh, E; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Concord Clinical School: MedicineValidating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity, Supportive Care in Cancer, vol.24, 3, 2016,pp 1209-1218